期刊
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
卷 89, 期 -, 页码 194-204出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.msec.2018.04.006
关键词
Human umbilical cord mesenchymal stem cells; Exosomes; Macrophage; Inflammatory cytokines; Spinal cord injury
资金
- National Natural Science Foundation of China, China [31670969]
- Guangdong Innovative and Entrepreneurial Research Program [201301S0105240297]
- Key Program of Traditional Chinese Medicine of Guangdong Province [20173018]
- National Science Foundation for Young Scientists of China, China [31500734]
- China Postdoctoral Science Foundation [2015M572411]
The exploration of effective spinal cord injury (SCI) healing still remain a great challenge due to the high morbidity, complex pathology and unclear targets. Human umbilical cord mesenchymal stem cells (hucMSC) play an important role in tissue regeneration. However, transplanting stem cells has a potential risk of teratogenicity. Recent studies have suggested that exosomes secreted by stem cells may contribute to tissue injury repair. We hypothesized that the application of hucMSC derived exosomes may be a potential way for SCI treatment. Our studies showed the hucMSC derived exosomes with a mean particle size of 70 nm could effectively trigger the bone marrow derived macrophage (BMDM) polarization from M1 to a M2 phenotype. In vivo studies demonstrated that the hucMSC derived exosomes could improve the functional recovery after SCI through down-regulation of the inflammatory cytokines, such as TNF-alpha, MIP-1 alpha, IL-6 and IFN-gamma. Collectively, our findings indicated that hucMSC derived exosomes could facilitate spinal cord injury healing via attenuating the inflammation of the injury region. Our results provided a new perspective and therapeutic strategy for the use of hucMSC derived exosomes in soft tissue repair.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据